🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
SCYNEXIS, Inc.
Market Cap: Lowest
Employees: Lowest
BREXAFEMME (ibrexafungerp tablets)
SCYNEXIS, Inc. is a biotechnology company focused on developing products for the treatment of fungal infections. They offer BREXAFEMME for the treatment of vulvovaginal candidiasis and are developing Ibrexafungerp, an oral and intravenous drug for various fungal infections.
Symbol: SCYX
Recent Price: $1.07
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. David Gonzalez Angulo M.D.
Sector: Healthcare
Employees: 29
Address: 1 Evertrust Plaza, Jersey City, NJ 07302-6548
Phone: 201 884 5485
Leadership
- Armando Anido, Director
- Steven C. Gilman, Ph.D., Director
- David Angulo, M.D., President and Chief Executive Officer
- Scott Sukenick, Chief Legal Officer
- Ivor Macleod, MBA, CPA, Chief Financial Officer
- Daniella Gigante, Vice President, Human Resources and Information Technology
- Rossana Ferrara-Pontoriero, Ph.D., Vice President, Business Development and Alliance Management
- Guy Macdonald, Chairman of the Board
- Ann F. Hanham, Ph.D., Director
- David Hastings, Director
- Philippe Tinmouth, Director
Last updated: 2024-12-31